NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-50 Cr | ₹-19 Cr | ₹12 Cr | ₹30 Cr | ₹41 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of NATCO PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-50 Cr |
| Mar2024 | ₹-19 Cr |
| Mar2023 | ₹12 Cr |
| Mar2022 | ₹30 Cr |
| Mar2021 | ₹41 Cr |
How is Deferred Tax Assets / Liabilities of NATCO PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-50 Cr | Negative | |
| Mar2024 | ₹-19 Cr | Negative | |
| Mar2023 | ₹12 Cr | -58.80 | |
| Mar2022 | ₹30 Cr | -27.12 | |
| Mar2021 | ₹41 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹16,457.5 Cr | -9.6% | -18.3% | 4.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,926.0 Cr | -1.2% | -2.3% | 5.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,062.0 Cr | -1% | -0.9% | -0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,806.0 Cr | -1.3% | 1.4% | 38.1% | Stock Analytics | |
| CIPLA | ₹112,910.0 Cr | -0.1% | 4.8% | -6.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,755.0 Cr | -2.8% | -0.3% | 1.2% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -9.6% |
-18.3% |
4.8% |
| SENSEX | -2% |
-3.8% |
-8.6% |
You may also like the below Video Courses